Masayuki Furukawa Selected Research

lenvatinib

10/2021

Improved indocyanine green retention after short-term lenvatinib withdrawal in three patients with hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayuki Furukawa Research Topics

Disease

16	Neoplasms (Cancer) 04/2024 - 09/2002
12	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 07/2015
5	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2024 - 01/2021
2	Neuroendocrine Carcinoma 07/2023 - 01/2020
2	Adenocarcinoma 01/2023 - 12/2022
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2022 - 09/2006
2	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 06/2020
2	Neoplasm Metastasis (Metastasis) 05/2019 - 05/2005
2	Infections 09/2010 - 11/2005
2	Nasal Polyps (Nasal Polyp) 06/2009 - 12/2002
2	Otitis Media with Effusion 09/2008 - 04/2002
2	Otitis Media 05/2007 - 11/2005
2	Hypersensitivity (Allergy) 11/2005 - 12/2002
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2024
1	Fibrosis (Cirrhosis) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Cholangiocarcinoma 01/2023
1	Adenosquamous Carcinoma 12/2022
1	Diabetes Mellitus 12/2022
1	Cachexia 10/2022
1	Gastric Outlet Obstruction 02/2022
1	Familial duodenal atresia 02/2022
1	Liver Neoplasms (Liver Cancer) 10/2021
1	Major Depressive Disorder (Major Depressive Disorders) 05/2021
1	Schizophrenia (Dementia Praecox) 05/2021
1	Fever (Fevers) 01/2021
1	Vaginal Neoplasms (Cancer, Vaginal) 01/2021
1	Hepatitis B 12/2020
1	Hypertension (High Blood Pressure) 06/2020
1	Disease Progression 01/2020
1	Ascites 07/2017
1	Myringosclerosis 01/2016
1	Abscess 08/2013
1	Squamous Cell Carcinoma of Head and Neck 04/2012
1	Middle Ear Cholesteatoma 01/2010

Drug/Important Bio-Agent (IBA)

10	Gemcitabine FDA Link 01/2023 - 07/2015
4	PlatinumIBA 01/2021 - 02/2017
3	130-nm albumin-bound paclitaxelIBA 01/2023 - 04/2019
3	Leucovorin (Folinic Acid)FDA Link 01/2023 - 01/2019
3	Peptides (Polypeptides)IBA 04/2019 - 12/2002
3	Platelet Activating FactorIBA 09/2008 - 04/2002
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024 - 02/2017
2	ZincIBA 09/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 08/2022
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 08/2022
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2013 - 11/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2012 - 05/2005
2	Proteins (Proteins, Gene)FDA Link 01/2010 - 06/2009
2	LeukotrienesIBA 12/2002 - 04/2002
1	niraparibIBA 04/2024
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2024
1	MicroRNAs (MicroRNA)IBA 07/2023
1	pemigatinibIBA 01/2023
1	folfirinoxIBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Dihydrotachysterol (AT 10)IBA 12/2022
1	CarbohydratesIBA 12/2022
1	AntigensIBA 12/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 10/2021
1	lenvatinibIBA 10/2021
1	brexpiprazoleIBA 05/2021
1	Antidepressive Agents (Antidepressants)IBA 05/2021
1	Dopamine (Intropin)FDA LinkGeneric 05/2021
1	Serotonin (5 Hydroxytryptamine)IBA 05/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	resminostatIBA 01/2021
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	ParaffinIBA 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2020
1	AntibodiesIBA 12/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2020
1	RamucirumabIBA 06/2020
1	Sorafenib (BAY 43-9006)FDA Link 06/2020
1	Everolimus FDA Link 01/2020
1	VaccinesIBA 04/2019
1	CrizotinibIBA 07/2017
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2015
1	arginyl- phenylalanyl- valyl- prolyl- aspartyl- glycyl- asparagyl- arginyl- isoleucineIBA 07/2015
1	Epidermal Growth Factor (EGF)IBA 04/2012
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 04/2012
1	Heparin (Liquaemin)FDA LinkGeneric 04/2012
1	flomoxefIBA 09/2010
1	Levofloxacin (Levaquin)FDA Link 09/2010
1	LigandsIBA 01/2010

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 12/2022 - 07/2003
6	Therapeutics 01/2023 - 01/2003
2	Combination Drug Therapy (Combination Chemotherapy) 02/2022 - 01/2022
2	Radiotherapy 01/2021 - 09/2006
1	Aftercare (After-Treatment) 01/2023
1	Pancreaticoduodenectomy 12/2022
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2022
1	Stents 02/2022
1	Operative Surgical Procedures 05/2019
1	Pancreatectomy 06/2017
1	Myringoplasty 01/2016